Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome.

Human pathology - 1 May 2010

Lin Pei, Luthra Rajyalakshmi, Nussenzveig Roberto H, Medeiros L Jeffrey

Abstract excerpt

The 3q21q26 syndrome is recognized as a distinct clinicopathologic entity. Patients have a myeloid neoplasm associated with 3q21q26 cytogenetic abnormalities and present with anemia, leukopenia, and either thrombocytosis or a normal platelet count associated with dysplasia. To determine if JAK2 V...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Chromosome Aberrations
Share to Chromosomes, Human, Pair 3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Leukemia, Myeloid, Acute

Share to Syndrome

Share to Thrombocytosis

Share to Thrombopoiesis

Source

Identifiers

PMID: 20153505
DOI: 10.1016/j.humpath.2009.11.004

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20153505-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome.PMID 20153505Read ↗

Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangementsSemantic proximity Read ↗

De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification.Semantic proximity Read ↗

Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group studySemantic proximity Read ↗

3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms.Semantic proximity Read ↗

Clinicopathologic and molecular characterization of myeloid neoplasms with isolated t(6;9)(p23;q34).Semantic proximity Read ↗

Cytokine receptor-like factor 3 (CRLF3) : a novel regulator of platelet biogenesis and potential drug target for thrombocythaemiaSemantic proximity Read ↗

Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndromeSemantic proximity Read ↗

Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.